Trans fatty acids, sometimes shortened to trans fats or TFA, are unsaturated fatty acids with at least one double bond in the trans configuration. Unsaturated fatty acids are derived metabolically from saturated fatty acids by the abstraction of pairs of hydrogen atoms from adjacent methylene groups. The removal of a pair of hydrogen atoms gives rise to a double bond. The remaining hydrogen atoms can either be on the same side of the fatty acid molecule, in which case the double bond has the cis geometrical configuration, or on opposite sides, giving the trans configuration. Trans fatty acids occur naturally in small amounts in a few foods, but the majority are formed during the partial hydrogenation of vegetable oils. This process converts vegetable oils into semi-solid fats for use in margarines, commercial cooking, and manufacturing processes. There is strong evidence that the consumption of trans fatty acids from industrial sources increases the risk of coronary artery disease (CAD).
Common sources of trans fats
SOURCE: American Heart Association.
Partially hydrogenated vegetable oils were favored by the food industry, as their high trans fatty acid content gave the oils a longer shelf life and an increased stability during deep frying (trans fatty acids have a higher melting point than some other types of fats). Their semi-solidity can be customized to enhance the palatability of baked goods and sweets. Because of consumer aversion to products containing trans fats, however, food producers have had to find trans fat–free alternatives.
The average consumption of industrially produced trans fatty acids in the United States is between 2%–3% of total calories consumed. The major sources of trans fatty acids in the American diet are deep-fried foods, bakery products, packaged snack foods, margarines, and crackers. Trans fatty acids are produced by a process called partial hydrogenation. Within the process, hydrogen gas is added to heated liquid vegetable oils while in the presence of a nickel catalyst, and then pressure is applied. The process causes a change in the arrangement of the hydrogen atoms in the fat molecules. Specifically, one or more hydrogen atoms are moved from one side of the molecule to the other. This causes the polyunsaturated fat molecules to act more like saturated fat molecules. The liquid vegetable oils now become solid at room temperature. Upon completion, the artificially reformulated oil is less greasy to the touch, remains fresher longer, is more difficult for the body to digest, and is less likely to spoil. Food manufacturers like to prepare foods with trans fatty acids rather than saturated animal fats or tropical oils, such as coconut oil, because it is less expensive.
There is no association between intake of trans fatty acids from ruminant sources and risk of CAD; in fact, some studies have shown nonsignificant trends toward an inverse association. The absence of a positive association of trans fatty acids from ruminant sources compared with industrial sources may be due to lower levels of intake (less than 0.5% of total energy intake), different biological effects of different isomers, or the presence of other factors in meat and dairy products that outweigh any effects of the small amount of trans fatty acids they contain. Further research in these areas is needed, although studies suggest that trans fatty acids from ruminant sources do not pose a threat to public health (at average intakes).
From 2000 to 2009, the U.S. Centers for Disease Control and Prevention (CDC) conducted the National Health and Nutrition Examination Survey (NHANES). Within the study, participants were tested with respect to trans fatty acids in their bloodstream. This specific period of the study was important, because the U.S. Food and Drug Administration (FDA) instituted regulations on trans fatty acids in 2003, which took effect in 2006. The new FDA regulations required that food manufacturers label the amount of trans fatty acids on the Nutrition Facts panel of product labels. The CDC study found that white adults in the United States decreased their intake of trans fatty acids by 58% from 2000 to 2009.
The main effects of trans fatty acids are on serum lipid levels. Numerous controlled dietary trials have been conducted to evaluate the effect of isocaloric replacement of saturated or cis unsaturated fatty acids with trans fatty acids. The data from many of these studies has been used in a number of large meta-analyses, all of which strongly indicate that compared with saturated or cis unsaturated fatty acids, the consumption of trans fatty acids raises levels of low-density lipoprotein (LDL) cholesterol (or “bad” cholesterol), reduces levels of high-density lipoprotein (HDL) cholesterol (or “good” cholesterol), and increases the ratio of total cholesterol to HDL cholesterol, all of which are powerful risk factors for CAD.
There is substantial evidence to show that trans fatty acids also promote systemic inflammation. In a large trial of women, greater intake of trans fatty acids was associated with increased activity of the tumor necrosis factor (TFN) system, a biomarker used to measure inflammation. Among those with a higher body mass index (BMI), a greater intake of trans fatty acids was also associated with other inflammatory substances. The presence of inflammation is an independent risk factor for atherosclerosis, sudden death from cardiac causes, diabetes mellitus, and heart failure. Thus, the inflammatory effects of trans fatty acids contribute further to overall CAD risk.
The risk to health of consuming trans fatty acids from industrial sources has been recognized and acknowledged by the U.S. government. In addition to the FDA labeling requirements, the U.S. Department of Agriculture (USDA) has made the limited intake of trans fatty acids a key recommendation of the new MyPlate guidelines (which replaces the former MyPyramid). This follows the recommendations of the Dietary Guidelines Advisory Committee that intake of trans fatty acids should be less than 1% of total energy. Action is also being taken at local levels. In 2008, New York became the first city to require restaurants and food suppliers to eliminate partially hydrogenated oils from kitchens and to provide foods free from industrially produced trans fatty acids. As of 2012, 12 other cities had followed suit, along with the entire state of California. Although the elimination of these trans fatty acids may be challenging, actions by other countries, such as Denmark, indicate that these fats can largely be replaced by cis unsaturated fats without impacting the cost or availability of foods.
To help ensure a reduction in trans fatty acid consumption, healthcare providers should advise consumers about how to minimize their trans fatty acid intake, consumers should learn to recognize and avoid products containing trans fatty acids, and restaurants and food manufacturers should use alternative fats in food production and preparation. All of these measures promote health benefits, particularly a reduction in the incidence of CAD.
On a per-calorie basis, trans fatty acids increase the risk of CAD more than any other macronutrient, conferring a substantially increased risk even at low levels of consumption (between 1%–3% of total energy intake). Even a small rise in energy intake from trans fatty acids can cause a large increase in risk. A meta-analysis of four prospective cohort studies, which included data from 140,000 subjects, showed a 23% increase in CAD incidence when energy intake from trans fatty acids increased by just 2%. Another study showed that the positive association between levels of trans fatty acids in adipose (fat) tissue, a biomarker for dietary intake, and CAD risk was diminished in Australia after trans fatty acids were eliminated from margarines and consumption levels decreased.
The potential benefits of reducing consumption of trans fatty acids from industrial sources on the incidence of CAD in the United States has been calculated. On the basis of predicted changes in total and HDL cholesterol, CAD events could be reduced by between 3%–6%. If the influence of trans fatty acids on other risk factors, such as inflammatory effects, is considered, CAD events could be reduced by 10%–19% (equivalent to between 72,000 and 228,000 CAD events each year). This reduction could be even greater if healthier cis unsaturated fatty acids, including omega-3 fatty acids, are used to replace trans fatty acids.
The association between risk of diabetes and trans fatty acid intake is less clear. Three prospective studies have investigated this relationship, and in two of the studies, consumption of trans fatty acids was not significantly associated with increased risk of diabetes. However, in a study of nearly 85,000 female nurses, a strong positive association was found. The nurses were followed for 16 years, with information on their dietary intake updated periodically and any self-reported diabetes validated. The conclusions of no association in the first two studies may be due to relatively low intake; further research is needed.
Parents should try to eliminate all sources of trans fatty acids from industrial sources from their children's diets, as they have no intrinsic health value above their energy value. As adverse effects are seen at even low levels of intake—between 1%–3% of total energy, or 2 to 7 grams per day for a person consuming 2,000 calories—it seems complete or near complete avoidance of trans fatty acids should be advised in order to minimize health risks in both children and adults.
See also Diet and disease prevention ; Dietary cholesterol ; Heart-healthy diets ; Low-cholesteroldiet ; Low-fat diet ; Omega-3 and omega-6 fatty acids .
Dijkstra, Albert J., Richard J. Hamilton, and Wolf Hamm, eds. Trans Fatty Acids. Oxford, UK: Blackwell, 2008.
Jones, Keith. Diet and Nutrition Sourcebook. 5th ed. Detroit: Omnigraphics, 2016.
Kummero, Fred A., et al. Cholesterol Won't Kill You, but Trans Fats Could: Separating Scientific Fact from Nutritional Fiction in What You Eat. Bloomington, IN: Trafford, 2008.
Leas, Connie. Fat: It's Not What You Think. Amherst, NY: Prometheus Books, 2008.
Mossoba, Magdi M., and John K. G. Kramer. Official Methods for the Determination of Trans Fats. 2nd ed. Urbana, IL: AOCS Press, 2009.
Whitney, Ellie, and Sharon Rady Rolfes. Understanding Nutrition. 14th ed. Belmont, CA: Cengage Learning, 2016.
Jarlenskia, Marian, and Colleen L. Barry. “News Media Coverage of Trans Fat: Health Risks and Policy Responses.” Health Communication 28, no. 3 (2013): 209–16. http://dx.doi.org/10.1080/10410236.2012.669670 (accessed April 19, 2018).
Willett, Walter C. “Dietary Fats and Coronary Heart Disease.” Journal of Internal Medicine 272, no. 1 (2012). http://dx.doi.org/10.1111/j.1365-2796.2012.02553.x (accessed April 19, 2018).
“New York City Passes Trans Fat Ban.” MSNBC.com , December 5, 2006. http://www.msnbc.msn.com/id/16051436/ns/health-diet_and_nutrition/t/new-yorkcity-passes-trans-fat-ban (accessed April 19, 2018).
American Heart Association. “Trans Fats.” http://www.heart.org/HEARTORG/GettingHealthy/FatsAndOils/Fats101/Trans-Fats_UCM_301120_Article.jsp (accessed April 19, 2018).
Center for Science in the Public Interest. “Trans Fat.” http://www.cspinet.org/transfat/index.html (accessed April 19, 2018).
Harvard T.H. Chan School of Public Health. “Shining the Spotlight on Trans Fats.” The Nutrition Source, Department of Nutrition, Harvard University. http://www.hsph.harvard.edu/nutritionsource/nutrition-news/transfats (accessed April 19, 2018).
Mayo Clinic staff. “Trans Fat is Double Trouble for Your Heart Health.” MayoClinic.com . http://www.mayoclinic.com/health/trans-fat/CL00032 (accessed April 19, 2018).
U.S. Centers for Disease Control and Prevention. “CDC Study Finds Levels of Trans-Fatty Acids in Blood of U.S. White Adults has Decreased,” press release, February 8, 2012. http://www.cdc.gov/media/releases/2012/p0208_trans-fatty_acids.html (accessed April 19, 2018).
U.S. Department of Agriculture and U.S. Department of Health and Human Services. “Foods and Food Components to Reduce.” In Dietary Guidelines for Americans, 2010, 7th ed., Washington, DC: U.S. Government Printing Office, December 2010. http://health.gov/dietaryguidelines/dga2010/DietaryGuidelines2010.pdf (accessed April 19, 2018).
U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans. 8th ed. December 2015. http://health.gov/dietaryguidelines/2015/guidelines/ (accessed May 1, 2018).
U.S. Food and Drug Administration. “Talking about Trans Fat: What You Need to Know.” Food Facts from the U.S. Food and Drug Administration, May 2006. http://www.fda.gov/downloads/food/resourcesforyou/consumers/ucm079646.pdf (accessed April 19, 2018).
Academy of Nutrition and Dietetics, 120 South Riverside Plz., Ste. 2000, Chicago, IL, 60606, (312) 899-0040, (800) 877-1600, email@example.com, http://www.eatright.org .
American Heart Association, 7272 Greenville Ave., Dallas, TX, 75231, (800) 242-8721, http://www.americanheart.org .
Center for Science in the Public Interest, 1220 L St. NW, Ste. 300, Washington, DC, 20005, (202) 332-9110, Fax: (202) 265-4954, http://www.cspinet.org .
Centers for Disease Control and Prevention, 1600 Clifton Rd. NE, Atlanta, GA, 30333, (800) CDC-INFO (232-4636), TTY: (888) 232-6348, firstname.lastname@example.org, http://www.cdc.gov .
Sarah E. Schenker, SRD, PhD, RPHNutr
Revised by William A. Atkins